PMID: 697950Sep 1, 1978Paper

Herpes zoster in patients with systemic lupus erythematosus

Arthritis and Rheumatism
H M MoutsopoulosA D Steinberg

Abstract

In the context of prospective trials of immunosuppressive drugs in systemic lupus erythematosus (SLE) nephritis, 83 patients were studied with regard to development of herpes zoster. Herpes zoster was found to occur with high frequency (21%) in patients with SLE nephritis treated with immunosuppressive agents. The course of herpes zoster was benign: no deaths occurred and only 2 of the 18 patients developed generalized disease, which resolved without sequelae. Specific antiviral therapy was not necessary and there appears to be no need to decrease immunosuppressive medications. Zoster occurred when the SLE was relatively inactive and did not exacerbate the SLE. No statistical difference in the incidence of zoster was found among the patient groups treated with different immunosuppressive regimens.

References

May 27, 1976·The New England Journal of Medicine·R J WhitleyC A Alford
Jan 1, 1969·Scandinavian Journal of Haematology·L Brandt, H Hedberg
Nov 1, 1974·Clinical Pharmacology and Therapeutics·C H Kirkpatrick
Jul 1, 1973·The American Journal of Medicine·B H HahnC K Osterland
Jan 1, 1974·Arthritis and Rheumatism·P J StaplesR S Gordon
Jul 1, 1972·Arthritis and Rheumatism·D A Horwitz
Jul 1, 1968·Annals of the Rheumatic Diseases·S R BlockL E Shulman
May 18, 1957·Journal of the American Medical Association·C F BURGOONG D BALDRIDGE
Sep 1, 1960·Annals of Internal Medicine·E SHANBROMH HAAR
Aug 1, 1961·Archives of Dermatology·E T WRIGHT, L H WINER
Jan 1, 1965·Clinical Pediatrics·S E KEIDAN, D MAINWARING
Sep 1, 1965·The American Journal of Medicine·J E SOKAL, D FIRAT

❮ Previous
Next ❯

Citations

Nov 1, 2003·Rheumatology International·Tae-Young KangDae-Hyun Yoo
Jul 5, 1979·The New England Journal of Medicine·J J HooksA L Notkins
Aug 28, 2014·Expert Review of Gastroenterology & Hepatology·Athanasios P DesalermosSharmeel K Wasan
Dec 22, 2012·Expert Opinion on Pharmacotherapy·Giancarlo ComiMatthew Scaramozza
Oct 1, 1989·The American Journal of the Medical Sciences·B A BaethgeL J Embree
Jul 20, 2010·Journal of Autoimmunity·Elena Kontaki, Dimitrios T Boumpas
Aug 3, 2010·Journal of Autoimmunity·Pierre Youinou
Apr 1, 1984·International Journal of Oral Surgery·M Schiødt
Jun 1, 1986·Journal of the American Academy of Dermatology·A E Friedman-KienB Poiesz
Dec 21, 2006·Pain Practice : the Official Journal of World Institute of Pain·David Niv, Alexander Maltsman-Tseikhin
Sep 30, 2008·Arthritis and Rheumatism·Eliza F Chakravarty
Dec 28, 2005·The American Journal of Medicine·Peter K WungUNKNOWN WGET Research Group
Dec 1, 1990·Baillière's Clinical Rheumatology·R A LuqmaniP A Bacon
Jun 8, 2013·Vaccine·Abigail R Cogman, Eliza F Chakravarty
Jun 4, 2002·Best Practice & Research. Clinical Rheumatology·Barri J Fessler
Dec 10, 2014·Nature Reviews. Rheumatology·Johanna WestraMarc Bijl
Aug 22, 2018·Human Vaccines & Immunotherapeutics·Chi Chiu Mok
Sep 17, 2013·The Journal of Rheumatology·Joel M GuthridgeEliza F Chakravarty
Jul 29, 2006·The Pediatric Infectious Disease Journal·Pamela P W LeeYu-Lung Lau
Jan 1, 1980·Annals of the New York Academy of Sciences·J J HooksA L Notkins
Feb 1, 1982·Annals of the Rheumatic Diseases·P H Feng, T H Tan
Oct 1, 1983·International Journal of Dermatology·H C Ting, F Wang
Mar 11, 2010·Journal of Clinical Rheumatology : Practical Reports on Rheumatic & Musculoskeletal Diseases·Eduardo F BorbaEloísa Bonfá
Dec 1, 1986·Annals of Neurology·R K PortenoyK M Foley
Sep 1, 1984·Rehabilitation Nursing : the Official Journal of the Association of Rehabilitation Nurses·R G Kinash
Feb 23, 2019·Expert Review of Gastroenterology & Hepatology·Samantha Zullow, Francis A Farraye
Feb 24, 2001·The Journal of Immunology : Official Journal of the American Association of Immunologists·D I Daikh, D Wofsy
Jun 2, 1998·Rheumatic Diseases Clinics of North America·M Petri

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.